U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671430) titled 'Assessment of the Benefits of Psychological Care Before Anterior Cruciate Ligament Surgery ... Read More
U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670234) titled 'Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential ... Read More
U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670416) titled 'A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, ... Read More
U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671833) titled 'A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects' on April 14. Brief Sum... Read More
U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671261) titled 'SEEG-Guided DBS for Schizophrenia' on June 22. Brief Summary: This is a prospective, rando... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More
Singapore, June 27 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More